Announced Wed, 8 Jul · 12:05 IST
Natco Pharma to raise stake in Adcock Ingram to 49 percent for Rs 1,069 cr
NATCOPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-2.2%1-day move
₹983.15
prior close
₹977.40
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.2-0.2+0.1+1.1-2.2+0.0-0.4-1.1-1.4-3.9————
Up moveDown movePending
AI summary
Natco Pharma board approved investing up to Rs 1,400 cr in its South African wholly-owned subsidiary and acquiring an additional 13.25 percent stake in Adcock Ingram Holdings for about Rs 1,069 cr, raising its holding from 35.75 percent to 49 percent. Adcock Ingram, a South African pharma firm with turnover of ZAR 9,760 million in FY25, will contribute 49 percent of its profits to Natco post-deal. Transaction expected to close by end of July 2026.
Likely market impact
Positive strategic move expanding African footprint; capital deployment of about Rs 1,069 cr may pressure short-term cash flows but boosts long-term earnings.